CIK 0001326110 · Large accelerated filer
ImmunityBio, Inc.
Sign in to watch- Ticker
- IBRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 431979754
- Phone
- (844) 696-5235
- Business address
- 3530 JOHN HOPKINS COURT, SAN DIEGO, CA, 92121
- Former names
- NantKwest, Inc., Conkwest, Inc., ZelleRx Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,119,848
- in 2 filings, $1.1M under 10b5-1 plans
Net −$1,119,848. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-05 | Adcock Richard CEO & President | Shares withheld for taxes | −42,192 | $4.33 | $183K | 185,582 |
| 2023-02-05 | Adcock Richard CEO & President | Option exercise · Restricted Stock Units | −83,333 | 83,334 | ||
| 2022-12-31 | Sachs David C. Chief Financial Officer | Option exercise | +7,598 | 51,298 | ||
| 2022-12-31 | Sachs David C. Chief Financial Officer | Option exercise · Restricted Stock Units | −7,598 | 136,793 | ||
| 2022-12-31 | Adcock Richard CEO & President | Option exercise | +8,620 | 148,714 | ||
| 2022-12-31 | Adcock Richard CEO & President | Shares withheld for taxes | −4,273 | $5.07 | $22K | 144,441 |
| 2022-12-31 | Adcock Richard CEO & President | Option exercise · Restricted Stock Units | −8,620 | 155,180 | ||
| 2022-12-12 | SOON-SHIONG PATRICK See remarks | Conversion | +9,986,920 | $5.67 | $56.6M | 9,986,920 |
| 2022-12-12 | SOON-SHIONG PATRICK See remarks | Conversion · Second Amended and Restated Convertible Promissory Note | −0 | |||
| 2022-08-31 | SOON-SHIONG PATRICK See remarks | Purchase · Amended and Restated Convertible Promissory Note | +0 | $40,407,671.00 | $0 | |
| 2022-08-31 | SOON-SHIONG PATRICK See remarks | Purchase · Amended and Restated Convertible Promissory Note | +0 | $55,927,342.00 | $0 | |
| 2022-08-31 | SOON-SHIONG PATRICK See remarks | Purchase · Second Amended and Restated Convertible Promissory Note | +0 | $63,375,911.00 | $0 | |
| 2022-08-31 | SOON-SHIONG PATRICK See remarks | Purchase · Second Amended and Restated Convertible Promissory Note | +0 | $55,844,638.00 | $0 | |
| 2022-08-31 | SOON-SHIONG PATRICK See remarks | Purchase · Second Amended and Restated Convertible Promissory Note | +0 | $59,524,425.00 | $0 | |
| 2022-08-31 | SOON-SHIONG PATRICK See remarks | Purchase · Second Amended and Restated Convertible Promissory Note | +0 | $40,016,261.00 | $0 | |
| 2022-06-14 | Selecky Christobel Director | Grant or award · Stock Option (right to buy) | +167,937 | 167,937 | ||
| 2022-06-14 | MAXWELL LINDA Director | Grant or award · Stock Option (right to buy) | +167,937 | 167,937 | ||
| 2022-06-14 | Cohen Cheryl Director | Grant or award · Stock Option (right to buy) | +167,937 | 167,937 | ||
| 2022-06-14 | Clark Wesley Director | Grant or award · Stock Option (right to buy) | +167,937 | 167,937 | ||
| 2022-06-14 | Brennan John Owen Director | Grant or award · Stock Option (right to buy) | +167,937 | 167,937 |
Page 11 of 12 · 226 trades